These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35297979)

  • 21. Elderly drivers and simulated visual impairment.
    Wood JM; Troutbeck R
    Optom Vis Sci; 1995 Feb; 72(2):115-24. PubMed ID: 7753525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual field requirements for driving in Europe: the risk of inaccurate interpretation of visual field findings when using the binocular Esterman programme.
    Innerdal C; Ekstrand JR; Wankel VD; Jørstad ØK
    Acta Ophthalmol; 2019 Sep; 97(6):e939-e941. PubMed ID: 30801982
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical review licensing outcomes in drivers with visual field loss in Victoria, Australia.
    Muir C; Charlton JL; Odell M; Keeffe J; Wood J; Bohensky M; Fildes B; Oxley J; Bentley S; Rizzo M
    Clin Exp Optom; 2016 Sep; 99(5):462-8. PubMed ID: 27530283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of Brief Screening Tools to Identify Impaired Driving Among Older Adults in Australia.
    Anstey KJ; Eramudugolla R; Huque MH; Horswill M; Kiely K; Black A; Wood J
    JAMA Netw Open; 2020 Jun; 3(6):e208263. PubMed ID: 32585021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of visual field loss on driving performance: evidence from on-road driving assessments.
    Racette L; Casson EJ
    Optom Vis Sci; 2005 Aug; 82(8):668-74. PubMed ID: 16127331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance-based visual field testing for drivers with glaucoma: A pilot study.
    Devos H; Ranchet M; Bollinger K; Conn A; Akinwuntan AE
    Traffic Inj Prev; 2018; 19(7):715-721. PubMed ID: 30407083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
    Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
    JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change blindness in simulated driving in individuals with homonymous visual field loss.
    Swan G; Xu J; Baliutaviciute V; Bowers A
    Cogn Res Princ Implic; 2022 May; 7(1):44. PubMed ID: 35569089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-road driving with moderate visual field loss.
    Bowers A; Peli E; Elgin J; McGwin G; Owsley C
    Optom Vis Sci; 2005 Aug; 82(8):657-67. PubMed ID: 16127330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vision screening of older drivers for preventing road traffic injuries and fatalities.
    Subzwari S; Desapriya E; Babul-Wellar S; Pike I; Turcotte K; Rajabali F; Kinney J
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006252. PubMed ID: 19160271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A traffic perimetry test that adheres to the European visual field requirements.
    Jørstad ØK; Jonsdottir TE; Zysset S; Rowe F
    Acta Ophthalmol; 2021 Jun; 99(4):e555-e561. PubMed ID: 32996716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vision screening of older drivers for preventing road traffic injuries and fatalities.
    Desapriya E; Wijeratne H; Subzwari S; Babul-Wellar S; Turcotte K; Rajabali F; Kinney J; Pike I
    Cochrane Database Syst Rev; 2011 Mar; (3):CD006252. PubMed ID: 21412894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elderly licensure laws and motor vehicle fatalities.
    Grabowski DC; Campbell CM; Morrisey MA
    JAMA; 2004 Jun; 291(23):2840-6. PubMed ID: 15199034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of useful field of view and other screening tests to on-road driving performance.
    Myers RS; Ball KK; Kalina TD; Roth DL; Goode KT
    Percept Mot Skills; 2000 Aug; 91(1):279-90. PubMed ID: 11011899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between neuropsychological tests and driver's license renewal tests in Parkinson's disease.
    Badenes D; Garolera M; Casas L; Cejudo-Bolivar JC; Zaragoza S; Calzado N; Aguilar M
    Traffic Inj Prev; 2018 Feb; 19(2):125-132. PubMed ID: 28759268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glaucoma and on-road driving performance.
    Haymes SA; LeBlanc RP; Nicolela MT; Chiasson LA; Chauhan BC
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3035-41. PubMed ID: 18326696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using Serial Trichotomization to Determine Fitness to Drive in Medically At-Risk Drivers.
    Krasniuk S; Crizzle AM
    Am J Occup Ther; 2024 Jan; 78(1):. PubMed ID: 38215305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness.
    Owen VM; Crabb DP; White ET; Viswanathan AC; Garway-Heath DF; Hitchings RA
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2449-55. PubMed ID: 18515585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effects of Visual Field Loss from Stroke on Performance in a Driving Simulator.
    Bro T; Andersson J
    Optom Vis Sci; 2022 Sep; 99(9):679-686. PubMed ID: 35914086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of indirect alcohol biomarkers for predicting recidivism of drunk-driving among previously convicted drunk-driving offenders: results from the recidivism of alcohol-impaired driving (ROAD) study.
    Maenhout TM; Poll A; Vermassen T; De Buyzere ML; Delanghe JR;
    Addiction; 2014 Jan; 109(1):71-8. PubMed ID: 24438112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.